Lenvatinib Plus Pembrolizumab vs Standard of Care for Previously Treated Metastatic Colorectal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study
J. Clin. Oncol 2024 Jun 04;[EPub Ahead of Print], A Kawazoe, RH Xu, P García-Alfonso, M Passhak, HW Teng, A Shergill, M Gumus, C Qvortrup, S Stintzing, K Towns, TW Kim, KK Shiu, J Cundom, S Ananda, A Lebedinets, R Fu, R Jain, D Adelberg, V Heinemann, T Yoshino, E ElezFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.